2096 J . Org. Chem., Vol. 62, No. 7, 1997
Sisti et al.
of LiAlH4 (3.0 g) in 200 mL of anhydrous ether, under argon
at 0 °C. The mixture was refluxed for 23 h and then chilled
in a brine/ice bath, and the excess LiAlH4 destroyed by
dropwise addition of 6 mL of water, 6 mL of a 15% NaOH
solution, and finally 10 mL of water. After being stirred for
an additional 2 h, the mixture was treated with 15 g of 1:1
mixture of anhydrous MgSO4 and anhydrous Na2SO4, placed
under an argon atmosphere, and stirred for 3 h. Acryloyl
chloride (2.4 g) was then added dropwise over a period of 10
min, and the reaction mixture was allowed to stir overnight.
The resulting mixture was filtered, and the filtrate was
concentrated to 50 mL, washed sequentially with 50 mL of
saturated NaHCO3 solution, brine, and water, dried over
Na2SO4, and concentrated under vacuum. Amide 2 was
obtained as a colorless oil (2.6 g, 63%) after flash column
purification (silica gel, 1:1 heptane/ether): IR (neat) 1656 and
1642 cm-1 (CdO); 1H NMR (CDCl3) δ 1.18 (d, J ) 6.6 Hz, 3H),
1.58 (m, 2H), 2.10 (apparent q, J ) 7.0, 7.4 Hz, 2H), 4.09 (m,
1H), 5.01 (m, 2H), 5.65 (m, 1H), 5.80 (m, 1H), 6.18 (m, 2H);
13C NMR (CDCl3) δ 20.9, 30.4, 36.0, 45.0, 114.9, 126.1, 131.3,
138.0, 164.9; MS m/ z 153 (M+), 138, 125, 98; HRMS calcd for
C9H15NO 153.1154, found 153.1154.
cinnamide was obtained as a colorless solid (3.2 g, 80%) after
flash column purification (silica gel, 1:1 heptane/CH2Cl2, then
CH2Cl2): mp 69-71 °C; IR (Nujol) 3276 (NH), 1656 cm-1
1
(CdO); H NMR (CDCl3) δ 1.20 (d, J ) 6.5 Hz, 3H), 1.59 (m,
2H), 2.11 (q, J ) 7.3 Hz, 2H), 4.16 (quintet, J ) 7.0, 7.7 Hz,
1H), 4.97 (m, 2H), 5.79 (m, 1H), 6.31 (N-H), 6.51 (d, J ) 15.5
Hz, 1H), 7.28 (m, 3H), 7.46 (m, 2H), 7.62 (d, J ) 15.7 Hz, 1H);
13C NMR (CDCl3) δ 20.9, 30.4, 36.1, 45.2, 114.9, 121.4, 127.7,
128.7, 129.5, 135.0, 138.0, 140.6, 165.4; MS m/ z 229 (M+), 175,
146, 131, 103, 84, 77.
The derived amide (0.5 g, 2.2 mmol) was treated with triflic
anhydride (0.74 g, 1.2 equiv) in anhydrous CH2Cl2 containing
diisopropylethylamine (0.39 g) at -60 °C and then with LiCN
(0.1 g) and 12-crown-4 (0.05 g). Azadiene 6 was obtained as a
light yellow oil (0.22 g, 43%) after flash column purification
(silica gel, 9:1 heptane/ether): IR (neat) 2221 (CN), 1629
(CdC), 1578 cm-1; (CdN); 1H NMR (CDCl3) δ 1.29 (d, J ) 6.2
Hz, 3H), 1.75 (m, 2H), 2.03 (q, J ) 7.0, 7.9 Hz, 2H), 3.96 (m,
1H), 5.01 (m, 2H), 5.80 (m, 1H), 6.96 (d, J ) 16.3 Hz, 1H),
7.38-7.55 (m, 6H); 13C NMR (CDCl3) δ 21.8, 30.6, 36.9, 63.4,
109.1, 115.1, 126.0, 127.7, 129.0, 130.1, 134.6, 137.7, 140.7,
142.2; MS m/ z 238 (M+), 223, 140, 129, 102, 91, 77; HRMS
calcd for C16H18N2 238.1470, found 238.1463.
1,2,3,7,8,8a -Hexa h yd r o-3-m eth yl-7-p h en ylin d olizin e-5-
ca r bon itr ile (7) a n d 1,2,3,7,8,8a -Hexa h yd r o-3-m eth yl-7-
p h en ylin d olizin e-5-ca r bon itr ile (8). Azadiene 6 (150 mg)
in 2 mL of anhydrous benzene was placed in an argon-flushed
10-mL capacity thick-walled glass tube, equipped with a
Rotoflo tap and a magnetic stirring bar, and heated under
closed conditions at 110 °C for 26 h. (CAUTION: Sealed tube
reactions should always be carried out behind a safety shield,
using thick-walled glass tubes.) After cooling, the solvent was
removed under vacuum and the residue was applied to a flash
column (silica gel, 5:1 heptane/ether). Indolizidines 7 and 8
(a 3:2 mixture of diastereomers) were obtained as a yellow oil
(110 mg, 73%). The mixture of isomers was separated by
HPLC (silica, 97:3.0:0.1 heptane/EtOAc/TEA).
Triflic anhydride (4.9 g, new or freshly distilled) was added
dropwise over 10 min to a cold (-60 °C, argon atmosphere)
solution of amide 2 (2.2 g, 15 mmol) and dry diisopropylethyl-
amine (2.9 g) in 40 mL of anhydrous CH2Cl2, and the resulting
mixture was stirred at -60 °C for 1 h. A suspension of LiCN
(0.7 g, predried for 2 h at 80 °C, 0.01 mmHg) in 40 mL of
anhydrous THF containing 12-crown-4 (0.36 g, 0.1 equiv) was
then added dropwise over a period of 10 min, and stirring was
continued for an additional 1 h at -60 °C. The reaction
mixture was warmed to -20 °C over a period of 15 min and
quenched with 50 mL of water. After the two layers were
separated and the aqueous phase was washed with ether, the
combined organic layers were washed with water, dried over
Na2SO4, and concentrated in vacuo. Purification by flash
chromatography (silica gel, 3:1 pentane/ether) gave azadiene
3 as a volatile yellow liquid (1.0 g, 42%): IR (neat) 2221 (CN),
Spectral data for 7: IR (neat) 2225 (CN), 1602 cm-1 (CdC);
1H NMR (CDCl3) δ 1.33 (d, J ) 6.2 Hz, 3H), 1.54 (m, 2H), 2.12
(m, 4H), 3.65 (m, 3H), 5.33 (s, 1H), 7.26 (m, 5H); 13C NMR
(CDCl3) δ 22.3, 30.9, 32.3, 36.7, 41.0, 57.3, 57.4, 116.6, 126.9,
127.2, 128.9, 144.0; MS m/ z 238 (M+), 223, 140, 115, 91; HRMS
calcd for C16H18N2 238.1470, found 238.1466.
1
1651 and 1623 (CdC), 1588 cm-1 (CdN); H NMR (CDCl3) δ
1.25 (d, J ) 6.2 Hz, 3H), 1.72 (m, 2H), 2.00 (q, J ) 7.5, 7.0 Hz,
2H), 3.90 (q, J ) 6.3 Hz, 1H), 5.01 (m, 2H), 5.79 (m, 1H), 5.98
(d, J ) 10.8 Hz, 1H), 6.16 (d, J ) 18.3 Hz, 1H), 6.57 (dd, J )
10.2, 7.2 Hz, 1H); 13C NMR (CDCl3) δ 21.7, 30.6, 36.7, 63.6,
108.7, 115.2, 127.6, 134.9, 137.7, 141.0; MS m/ z 162 (M+), 147,
107; HRMS calcd for C10H14N2 162.1157, found 162.1168.
1,2,3,7,8,8a -Hexa h yd r o-3-m eth ylin d olizin e-5-ca r bon i-
tr ile (4) a n d 1,2,3,7,8,8a -Hexa h yd r o-3-m eth ylin d olizin e-
5-ca r bon itr ile (5). Azadiene 3 (100 mg, 0.6 mmol) in 4.0 mL
of anhydrous benzene was placed in an argon-flushed 10-mL-
capacity thick-walled glass tube, equipped with a Rotoflo tap
and a stirring bar, and stirred under closed conditions at 110
°C (oil bath temperature) for 24 h. (CAUTION: Sealed tube
reactions should always be carried out behind a safety shield,
using thick-walled glass tubes.) After cooling, the solvent was
removed and the residue applied to a flash column (silica gel,
1:1 heptane/ether). Indolizidines 4 and 5, a 4:1 mixture of
diastereomers, were obtained as a yellow oil (94 mg, 94%
overall). The mixture of isomers was separated by HPLC
(reverse phase: Hypersel C-8; 55:45:0.1 MeOH/H2O/TEA).
Spectral data for 4: IR (neat) 2223 (CN), 1639 cm-1 (CdN);
1H NMR (CDCl3) δ 1.20 (m, 2H), 1.28 (d, J ) 6.2 Hz, 3H), 1.52
(m, 2H), 1.81 (m, 1H), 2.02-2.20 (m, 3H), 3.36 (m, 1H), 3.61
(m, 1H), 5.34 (t, J ) 4.2 Hz, 1H); 13C NMR (CDCl3) δ 22.1,
23.1, 26.0, 30.6, 31.3, 57.0, 57.2, 113.7, 117.0, 119.2; MS m/ z
162 (M+), 147, 138, 119, 93, 80, 67; HRMS calcd for C10H14N2
162.1157, found 162.1159.
Spectral data for 8: IR (neat) 2224 (CN), 1602 cm-1 (CdC).
1H NMR (CDCl3) δ 1.19 (d, J ) 6.4 Hz, 3H), 1.58 (m, 2H), 1.99
(m, 4H), 3.13 (m, 1H), 3.63 (t, J ) 5.6 Hz, 1H), 3.97 (m, 1H),
5.44 (d, J ) 5.5 Hz, 1H), 7.14-7.35 (m, 5H); 13C NMR (CDCl3)
δ 21.8, 30.0, 31.3, 37.4, 39.1, 52.6, 55.5, 112.8, 116.3, 118.8,
126.6, 128.4, 128.5, 146.0; MS m/ z 238 (M+), 223, 199, 161,
140, 115, 91; HRMS calcd for C16H18N2 238.1470, found
238.1471.
N-[6-(1-Hepten yl)]-2-cyan o-1-azabu ta-1,3-dien e (9). Us-
ing the procedure described for the preparation of the azadiene
3, the syn- and anti-6-hepten-2-one oximes (1.7 g, 13.9 mmol)
prepared from 6-hepten-2-one15 were reacted with acryloyl
chloride. The derived amide was obtained as a colorless oil
(1.6 g, 70%) after flash column purification (silica gel, 1:1 hep-
tane/ether): IR (neat) 3276 and 3077 (NH), 1629 cm-1 (CdO);
1H NMR (CDCl3) δ 1.16 (d, J ) 6.4 Hz, 3H), 1.45 (m, 4H), 2.05
(q, J ) 6.5, 7.0 Hz, 2H), 4.06 (quintet, J ) 7.0, 8.1 Hz, 1H),
4.98 (m, 2H), 5.60 (dd, J ) 2.2, 8.0 Hz, 1H), 5.78 (m, 1H), 5.92
(NH), 6.16 (m, 2H); 13C NMR (CDCl3) δ 20.9, 25.4, 33.6, 35.4,
45.3, 114.8, 126.0, 131.3, 138.5, 164.9; MS m/ z 167 (M+), 152,
143, 134, 126; HRMS calcd for C10H17NO 167.1309, found
167.1309.
The above amide (1.5 g, 9.0 mmol) was treated with triflic
anhydride (3.0 g, 1.2 equiv) in anhydrous CH2Cl2 containing
diisopropylethylamine (1.7 g, 1.5 equiv) at -60 °C and then
with LiCN (0.4 g, 1.4 equiv) and 12-crown-4 (0.2 g, 0.1 equiv).
Azadiene 9 was obtained as a light oil (0.7 g, 43%) after flash
column purification (silica gel, 3:1 heptane/ether): IR (neat)
2221 (CN), 1588 cm-1 (CdN); 1H NMR (CDCl3) δ 1.24 (d, J )
6.2 Hz, 3H), 1.33 (m, 2H), 1.63 (m, 2H), 2.06 (q, J ) 7.0 Hz,
2H), 3.87 (q, J ) 6.3 Hz, 1H), 4.99 (m, 2H), 5.78 (m, 1H), 5.95
(d, J ) 10.6 Hz, 1H), 6.15 (d, J ) 17.6 Hz, 1H), 6.56 (dd, J )
10.6, 6.9 Hz, 1H); 13C NMR (CDCl3) δ 21.8, 33.6, 37.1, 64.1,
Spectra data for 5: IR (neat) 2223 (CN), 1639 cm-1 (CdN);
1H NMR (CDCl3) δ 1.13 (d, J ) 6.5 Hz, 3H), 1.22 (m, 2H), 1.61
(m, 2H), 2.08 (m, 4H), 3.22 (m, 1H), 3.85 (quintet, J ) 6.6 Hz,
1H), 5.32 (m, 1H); 13C NMR (CDCl3) δ 21.4, 23.7, 29.0, 30.3,
31.2, 55.1, 57.2, 113.4, 116.4, 117.8; MS m/ z 162 (M+), 147,
138; HRMS calcd for C10H14N2 162.1157, found 162.1155.
N-[5-(1-H exen yl)]-2-cya n o-4-p h en yl-1-a za b u t a -1,3-d i-
en e (6). Following the procedure described for the preparation
of azadiene 3, 5-hexene-2-one oxime (2.0 g, 17 mmol) was
reduced using LiAlH4 in anhydrous ether. N-[5-(1-Hexenyl)]-